Home > Cardiothoracic Surgery > Meet Our Team > Daniel Goldstein MD

Daniel J. Goldstein, MD

Montefiore-Einstein Medical Center
3400 Bainbridge Avenue
Bronx, New York 10467
Phone: 718-920-2144
dgoldste@montefiore.org

Positions and Appointments

  2000   Clinical Instructor, Cardiothoracic Surgery
Columbia Presbyterian Medical Center, New York, N.Y.
       
  2000   Assistant Attending, Cardiothoracic Surgery
Columbia University, College of Physicians and Surgeons, New York, N.Y. 
       
  2002-2005   Surgical Director of Cardiac Transplantation and Mechanical Assistance
Newark Beth Israel Medical Center, Newark, N.J. 
       
  2002-2005   Assistant Director of Cardiothoracic Fellowship
Newark Beth Israel Medical Center, Newark, N.J.
       
  2002-2005   Attending Staff, Department of Cardiothoracic Surgery
Newark Beth Israel Medical Center, Newark, N.J.
       
  2002-2005   Attending Staff, Department of Cardiothoracic Surgery
Saint Barnabas Hospital 
       
  2005-present   Associate Professor
Albert Einstein College of Medicine, Bronx, N.Y.
       
  2005-present   Attending Staff, Department of Cardiothoracic Surgery
Montefiore Medical Center, Bronx, N.Y.
       
  2005-present   Surgical Director of Cardiac Transplantation and
Mechanical Assistace Programs
Montefiore Medical Center, Bronx, N.Y.


 




Education and Training

  1987     Brandeis University, BA with High Honors
Waltham, Mass.
         
  1991     Medical Degree
Mount Sinai School of Medicine, New York, N.Y.
         
  1991-1997     Intern/ Resident, General Surgery
Columbia-Presbyterian Medical Center, New York, N.Y.
         
  1994-1995      Research Fellow, Division of Cardiothoracic Surgery
Columbia University, New York, N.Y.
         
  July-Dec. 1997     Electrophysiology Fellow, Division of Cardiothoracic Surgery
Columbia University, New York, N.Y.
Supported by a grant from Intermedics Inc., Texas ($23,000)
         
  Jan. 1998-
Dec. 1999
     Cardiothoracic Fellow, Division of Cardiothoracic Surgery,
Columbia University, New York, N.Y.
         
  Oct. 1-
Nov. 30, 1998
     Cardiothoracic Fellow, Division of Thoracic Surgery,
Memorial Sloan Kettering Hospital, New York, N.Y.

Board and Other Certifications

  1991    Diplomate of the National Board of Medical Examiners
       
  1992    Advanced Trauma Life Support
       
  1996    New York State Infection Control
       
  1998    Diplomate of the American Board of Surgery
       
  2000    United Network for Organ Sharing
       
  2001    Diplomate of the American Board of Thoracic Surgery

Honors and Awards

  1987   Magna Cum Laude
Phi Beta Kappa
Dean’s List 1984-87
       
  1991   Alpha Omega Alpha
Dr. Harold Lamport Biomedical Research Award - Best Research by Graduating Medical Student
       
  1994   General Surgery Research Start-Up Award ($1,000)
       
  1994   Blakemore Research Award for Outstanding Research
       
  1995   Blakemore Research Award for Outstanding Research
       
  1995   Claire Lucille Pace Humanitarian Award – Guatemala Heart Team
       
  1996   Administrative Chief Resident
       
  1997   Blakemore Research Prize to Graduating Senior for Outstanding Research
 
 
  1997   Arnold P. Gold Teaching Resident Award
 
 
  1998   Best Teaching Resident of the Year, presented by the Department of Surgery
     
  2000   Doody’s Rating Top 250 Best Health Science Book, for Minimally Invasive Cardiac Surgery
     
  2001   Harvey E. Nussbaum, MD, American Heart Association Award for Distinguished Service
     
  2002   AHA Council on Vascular and Thoracic Surgery Travel Grant ($1,000)
     
  2005   Member, International Scientific Committee, World Society of Cardiothoracic Surgeons
     
  2007   “Surgeon of the Year” Award, awarded by the Critical Care Service, Montefiore Medical Center


Hospital Committees

  2002-2005   Graduate Medical Education Committee 
Newark Beth Israel Medical Center, Newark, N.J.
       
  2005-Present   Outreach Select Standing Committee
Montefiore Medical Center, Bronx, N.Y.

Memberships

  • International Society of Heart and Lung Transplantation
  • American Medical Association
  • Healing the Children, New York Chapter
  • American Heart Association Council Member, Cardiothoracic and Vascular Surgery
  • Fellow, American College of Cardiology
  • Fellow, American College of Surgeons
  • Member, Society of Thoracic Surgeons

Clinical Research Trials/IRB Trials

Newark Beth Israel Medical Center

  2001-2003   Principal Investigator, Safety and Feasibility Trial of the Micromed (Debakey/NASA) Axial Flow Pump as a Bridge to Transplantation  ($5,000/patient) - $150,000. Sponsor: MicroMed
       
  2002-2004   Co-Principal Investigator, Evaluation of Inhaled Nitric Oxide for the Treatment of Right Heart Failure/Pulmonary Hypertension Following LVAD Placement and Cardiac Transplantation ($5,000/patient) - $5000
       
  2002-2004    Co-Principal Investigator, Multicenter Evaluation of Safety and Efficacy of ERLO80A Compared to Mycophenolate  Mofetil in De Novo Heart Transplant Recipients. ($14,252/patient) - $57,000
       
  2002-2004    Principal Investigator, Clinical Evaluation of Acorn Cardiac Support Device Therapy in Patients with Dilated Cardiomyopathy ($13,000/patient)- $52,000. Sponsor: ACORN Cardiovascular
       
  2002-2005    Principal Investigator, Multicenter Evaluation of the MicroMed DeBakey VAD as a Bridge to Transplantation: The Pivotal Trial. ($5,000/patient) - $15,000. Sponsor: MicroMed
       
  2003-2005    Principal Investigator, Randomized Evaluation of the MicroMed DeBakey VAD as Permanent Therapy. ($9,000/patient) - $9,000. Sponsor: MicroMed


Montefiore/Albert Einstein Medical Centers (IRB Approved)

  2005-Present    Principal Investigator, Clinical Evaluation of the HeartMate II Axial Flow Device as a Bridge to Transplant. ($5,500/patient). Sponsor: Thoratec Inc.
       
  2005-Present    Principal Investigator, Randomized Evaluation of the HeartMate II Axial Flow Device versus the HeartMate XVE as Destination Therapy ($7,500/patient). Sponsor: Thoratec Inc.
       
  2005-Present     Principal Investigator, The Biology of Human Long-Term Mechanical Support. NHLBI SCCOR Grant. RFA   HL-03-009*. ($1500 – $7150 per patient)
 *Includes 3 Trials:
  • Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation or Implantation of Left Ventricular Assist Device
  • Epidemiology of Device-Related Infections
  • The Effect of Intramyocardial Injection of Immunoselected Bone Marrow Cells on Myocardial Function in LVAD Bridge to Transplant Patients
       
  2005-Present    Principal Investigator, AB 5000 Circulatory Support System Data Registry
       
  2005-Present    Principal Investigator, Interagency Registry of Mechanically Assisted Circulatory Support
       
  2005-Present    Co-Investigator, Surgical Treatment for Ischemic Heart Failure (STICH) trial
       
  2007-Present    Co-Principal Investigator, Montefiore HARPS Protocol – Use of Clenbuterol in Recipients of Ventricular Assist Devices as a Bridge to Recovery
       
  2007-Present    Co-Principal Investigator, Multicenter, double blind, randomized, placebo-controlled parallel group study to assess the efficacy, safety and tolerability of tezosentan in patients with preoperative pulmonary hypertension, due to left heart disease, undergoing cardiac surgery

Other Activities

  2006-Present   Member, Clinical Events Committee. Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS HF) Trial
       
  2007-Present   Member, Program Committee. New York State Thoracic Society


Publications and Presentations

Journals

  1. Zaghouani H, Goldstein DJ, Shah H, Anderson S, Lacroix M., Kennedy R, Bona C. Induction of antibodies to the envelope protein of the HIV virus by sensitization of rabbits with monoclonal anti-idiotypes. Proc Nat Acad Sci 1991;88(13):5645-49.

  2. Oz MC, Goldstein DJ, Rose EA. Adjustable annuloplasty for tricuspid insufficiency. Ann Thorac Surg 1994;58:594-95.

  3. Goldstein DJ, El-Amir N, Ashton RA, Catanese K,  Rose EA, Levin HR , Oz MC. Fungal infections in left ventricular assist device recipients: incidence, prophylaxis and treatment. ASAIO 1995;41:873-75.

  4. Goldstein DJ, Oz MC, Rose EA, Fisher P, Michler RE. Experience with heart transplantation for cardiac tumors. J Heart Lung Transpl 1995;14:382-86.

  5. Goldstein DJ, Seldomridge JA, Addonizio L, Oz MC, Michler RE. Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol 1995;75:968-71.

  6. Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC. Use of aprotinin in LVAD recipients reduces blood loss, blood use and perioperative mortality. Ann Thorac Surg 1995;59:1063-68.

  7. Goldstein DJ, Mullis SL, Delphin ES, El-amir N, Ashton RC, Gardocki M, Jordan DA, Catanese KA, Levin HR, Oz MC. Non cardiac surgery in long term implantable LVAD recipients. Ann Surg 1995;222:203-07.

  8. Slater JP, Goldstein DJ, Ashton RC, Levin HR, Spotnitz HM, Oz MC. Right-to-left venoarterial shunting for right sided circulatory failure. Ann Thorac Surg 1995;60:978-85.

  9. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE. De novo malignancies after orthotopic cardiac transplantation. Ann Thorac Surg 1995;60:1783-89.

  10. Goldstein DJ, DeRosa CM, Mongero L, Weinberg AD, Michler RE, Rose EA, Oz MC, Smith CR. Safety and efficacy of aprotinin in profound hypothermia and circulatory arrest. J Thorac Cardiovasc Surg 1995;110:1615-22.

  11. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson S, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. Screening scale predicts patients succesfully receiving long-term implantable LVAD. Circulation 1995;92[suppl II]:II-169-II-173

  12. Slater JP, Yamada A, Yano OJ, Stennet R, Goldstein DJ, Levin HR, Spotnitz HM, Oz MC. Creation of a controlled venoarterial shunt: A surgical intervention for right-sided circulatory failure. Circulation 1995;92[suppl II]:II-467-II-471.

  13. Goldstein DJ, Oz MC, Michler RE. Radical excisional therapy and cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg 1995;60:1105-07.

  14. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach. J Cardiac Surg 1995;10:288-94.

  15. Rose EA, Goldstein DJ. Wearable long term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg 1996;61:399-402.

  16. Goldstein DJ, Smith CR, Oz MC, Friedlander J, Mongero L, Delphin E.  Safety of repeat aprotinin administration for left ventricular assist device recipients undergoing cardiac transplantation. Ann Thorac Surg 1996;61:692-95.

  17. Goldstein DJ, Austin JHM, Zuech N, Williams DL, Stoopler MB, Michler RE, Schulman LL. Lung cancer after heart transplantation. Transplantation  1996;62(6):772-75.

  18. Catanese KA, Goldstein DJ, Williams DL, Foray AT, Illick CD, Gardocki MT, Weinberg AD, Levin HR, Rose EA, Oz MC. Outpatient left ventricular assist device support: a new destination rather than a bridge. Ann Thorac Surg  1996;62:646-53.

  19. Beck J, Mongero L, Goldstein DJ, Oz MC. Perfusion technique for the treatment of right heart failure. Perfusion 1995;10:323-26.

  20. Ashton RC, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC. Duration of LVAD support affects transplant survival. J Heart Lung Transpl 1996;15:1151-57.

  21. Ashton RC, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC.  The development of a transluminal device for the treatment of aortic regurgitation: prototype and testing system. J Thorac Cardiovasc Surg 1996;112:979-83.

  22. Oz MC, Argenziano M, Catanese KA, Gardocki M, Goldstein DJ, Ashton RC, Rose EA, Levin HR. Bridge experience with long-term implantable left ventricular assist device: are they an alternative to transplantation ?. Circulation 1997;95:1844-52.

  23. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin RE, Cohen D. Cyclosporine induced end stage nephropathy after cardiac transplantation; incidence and progression. Transplantation 1997;63:664-68.

  24. Holubarsch C, Ruf T, Goldstein DJ, Ashton RC,  Nickl W, Pieske B, Pioch K, Ludmann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D. Existence of the Frank-Starling mechanism in the failing human heart. Circulation 1996;94:683-89.

  25. Goldstein DJ, Ashton RC, Slater JP, Pearson M, Seldomridge JA, D’Alessandro D, Jordan DA, Oz MC. Venoarterial shunting for the treatment of right sided circulatory failure following left ventricular assist device placement. ASAIO J 1997;43(3):171-76.

  26. Goldstein DJ, Moazami N, Seldomridge JA, Liao H, Ashton RC, Naka Y, Pinsky DJ, Oz MC. Circulatory resuscitation with 30 day left ventricular assist device reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997;63:971-74.

  27. Goldstein DJ, Dean D, Smerling A, Oz MC, Dickstein M. Inhaled nitric oxide Is not a negative inotrope in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg 1997;114:461-66.

  28. Argenziano M, Dean DA, Moazami N, Williams M, Goldstein DJ, Rose EA, Spotnitz HM, Burkhoff D, Oz MC, Dickstein ML. Inhaled nitric oxide does not alter systolic or diastolic myocardial function in a porcine model of heart failure. J Thorac Cardiovasc Surg 1998;115:700-08.

  29. Goldstein DJ, Garfein E, Zuech N, Michler RE. Mitral valve replacement and tricuspid annuloplasty following cardiac transplantation. Ann Thorac Surg. 1997;63:1463-65.

  30. Goldstein DJ, DeRosa C, Seldomridge JA, Weinberg AD, Oz MC, Smith CR. Is aprotinin indicated for reoperative valvular surgery?.  J Heart Valve Dis 1997;6:88-92.

  31. Goldstein DJ, Argenziano M, Oz MC. Permanent mechanical circulatory support: pitfalls and promises. Contemporary Treatments in Cardiovascular Diseases 1997;2:209-25.

  32. Goldstein DJ, Flores R, and Todd G. Rupture of non-aneurysmal atherosclerotic infrarenal aorta. J Vasc Surg 1997;26:700-03.

  33. Flores RM, Goldstein DJ, Sung RS, Steinglass K, Weinsten S, Chabot JA. Transthoracic transdiaphragmatic excision of simultaneous lung and adrenal lesions.  Ann Thorac Surg 1998;65:833-34.

  34. Slater JP, Lipsitz EC, Chen JM, Levin HR, Oz MC, Goldstein DJ, Ashton RC, Burkhoff D. Systolic ventricular interaction in normal and diseased explanted human hearts.  J Thorac Cardiovasc Surg 1997;113:1091-99.

  35. Goldstein DJ, Choudhri A, Argenziano M, Ulmer B, Oz MC. Repeat administration of aprotinin for staged cardiac transplantation. J Circ Support 1998;1:27-30.

  36. Argenziano M, Goldstein DJ, Catanese KA, Flannery M, Gardocki MT, Rose EA, Scully BE, Oz MC. Management of infections involving the left ventricular assist device surface. J Circ Support 1998;1:31-36.

  37. Farman J, Goldstein DJ, Sugalski M, Moazami N, Amory S. Bouveret’s syndrome: diagnosis by helical CT scan. Clinical Imaging 1998;22:240-42.

  38. Harig B, Goldstein DJ, Rosen Y, Farman J. Colonic obstruction due to sigmoid muscle hyperplasia. Mt Sinai J Med 1999;66:106-8.

  39. Argenziano M, Dean D, Moazami N, Williams M,Goldstein DJ, Cabreriza S, Burkhoff D, Smerling A, Rose EA, Oz MC, Dickstein M. Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg 1998;115:700-08.

  40. Michler RE, Goldstein DJ. Cardiac transplantation for primary cardiac neoplasms.  Seminars in Oncology 1997;24:534-39.

  41. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. PACE 1998;21:1730-34.

  42. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. New Engl J Med 1998;339(21):1522-33.

  43. Hart J, Cabreriza S, Jia CX, Umana J, Goldstein DJ, Hill-Edgar A, Weinberg AD, Galantowicz ME, Dickstein M, Burkhoff D, Rose EA, Spotnitz HM. Left ventricular function in a porcine model of dilated cardiomyopathy during left ventricular reduction surgery. Surg Forum 1998;49:246-8.

  44. Rose EA, Moskowitz A, Packer M, Sollano J, Williams D, Tierney A, Heitjan D, Meier P, Ascheim D, Levitan R, Weinberg A, Stevenson L, Watson J, Goldstein D, Gelijns A. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure: rationale, design and endpoints. Ann Thorac Surg 1999; 67:723-30.

  45. Goldstein DJ, Rabkin D, Spotnitz HM. Unconventional approaches to cardiac pacing in patients with inaccessible cardiac chambers. Ann Thorac Surg 1999;67:952-8.

  46. Rabkin D, Goldstein DJ, Flores R, Benvenisty AI. Spontaneous popliteal artery dissection. J Vasc Surg 1999;29:737-40.

  47. Goldstein DJ, Oz MC. Minimally invasive cardiac surgery: present status and future directions. Curr Op in Cardiol. 1999:14:419-25.

  48. Morales DLS, Catanese KA, Helman DN, Williams MR, Weinberg A, Goldstein DJ, Rose EA, Oz MC. Six-year experience of caring for 44 LVAD patients at home: safe, economical and necessary.  J Thorac Cardiovasc Surg 2000;119:251-9.

  49. Rabkin D, Sladen R, Dimango A, Steinglass K, Goldstein DJ.Inhaled nitric oxide for the treatment of postpneumonectomy pulmonary edema. Ann Thorac Surg 2001;72:272-4.

  50. Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Sem Thorac Cardiovasc Surg 2000;12:220-8.

  51. Youssuf A, Karanam R, Prendergast T, Saunders C, Hertz S, Brener B, Sardari F, Goldstein DJ. Combined off pump and carotid revascularization: early experience.  Ann Thorac Surg 2001;72:1542-5.

  52. Kukuy E, Goldstein D, Rao V, Edwards N, Naka Y. A simple method of creating LVAD outflow anastomosis. Heart Surgery Forum 2002;6(1).

  53. Goldstein DJ. Invited Commentary. In: Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg  2002;74:751-2.

  54. Goldstein DJ, Beauford R, Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. Multivessel off pump revascularization in patients with severe left ventricular dysfunction. Eur J Cardiothorac 2003;24:72-80.

  55. Beauford R, Goldstein D, Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. Multivessel off pump revascularization in octagenarians. Ann Thorac Surg 2003 ;76:12-7.

  56. Goldstein DJ. Worldwide experience with the MicroMed DeBakey VAD as a bridge to transplantation. Circulation2003;108:II272-7

  57. Goldstein DJ, Beauford R. Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 2003;75:S42-7.

  58. Beauford R, Saunders CR, Goldstein DJ. Combined off-pump coronary revascularization and carotid endarterctomy. J Cardiovasc Surg 2003;44:407-15

  59. Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and Goldstein D. Is off pump revascularization better for patients with non-dialysis dependent renal insufficiency?  Heart Surg Forum 2004 7(2):E141-6.

  60. Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and Goldstein D. Multivessel off pump revascularization for patients with left main disease. J Card Surg 2005:20:112-8.

  61. Goldstein DJ, Zucker M, Arroyo L, McCarthy P, Noon G. Safety and efficacy trial of the MicroMed DeBakey VAD as a Bridge to transplantation. J Am Coll Cardiol 2005;45:962-3

  62. Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, WeinbergAD, Prendergast TW, Ribner HS: De novo immunosuppression with sirolimus and  tacrolimus in heart transplant recipients ccompared with cyclosporine and mycophenolate mofetil - a one year follow-up analysis. Transpl Proc 2005;37:2231-9

  63. Baran DA, Gass Al, Galin I, Zucker M, Arroyo L, Goldstein DJ, Prendergast T, Lubitz S, Courtney M, Correa R, Chan M, Spielvogel D, Lansman S. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device. J Heart Lung Transpl 2005:24:1886-90.

  64. Goldstein DJ. Advances in Hematology: Coagulation and Thrombotic Complications Associated with Ventricular Assist Devices. Clin Adv Hematol Oncol 2005 3;10:766-8.

  65. Goldstein DJ, Smego D, Michler RE. Surgical aspects in congestive heart failure. Heart Fail Rev. 2006;11:171-192.

Online Contributions

  1. Dewey T, Goldstein DJ, Oz MC. TCI Heartmate insertion. Cardiothoracic Surgery Network: Expert’s Techniques. Online: www.ctsnet.org/section/experts, 1999.

  2. Rose EA, Goldstein DJ. Role of Left Ventricular Assist Devices as a Bridge to Transplantation. In: Braunwald E, ed. Harrison’s Online. McGraw-Hill 1999.

Book Contributions

  1. Goldstein DJ, Costanzo MR, Rose EA. Novel Cardiac Replacement Therapies: A Vision for the Future. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.255-61. 1998

  2. Goldstein DJ, Rose EA. Cardiac Allotransplantation. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.177-84. 1998

  3. Goldstein DJ, Oz MC. What is Minimally Invasive ? In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.1-5. Humana Press Inc., Totowa, NJ.

  4. Lemole G, Choudhri A, Oz MC, Goldstein DJ, Gianguzzi R, Nguyen H. Economic Impact of Minimally Invasive Approaches. In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.165-72. Humana Press Inc., Totowa, NJ.

  5. Goldstein DJ. The ThermoCardiosystems Device. In: Cardiac Assist Devices. Goldstein DJ, Oz MC, eds. Futura Publishing, Copyright 2000.

  6. Gibson M, Beauford R, Goldstein DJ. The Octopus Device. In: Minimally Invasive Cardiac Surgery. M. Oz, D Goldstein, Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003

  7. Goldstein DJ, Beauford R, Saunders CR. Beating Heart Revascularization in High-Risk Scenarios: The Patient with Severe Left Ventricular Dysfunction. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003

  8. Sardari F, Beauford R, Goldstein DJ. Beating Heart Revascularization in High-Risk Scenarios: The Octagenarian Patient. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003

  9. Goldstein DJ, Zucker MJ, Pagani F, Frazier OH. Rotary Ventricular Assist Devices. In: International Society for Heart & Lung Transplantation Monograph Series. Frazier OH, Kirklin JK, eds. Volume 1. p77-104. Copyright 2006

Books

  1. Oz MC, Goldstein DJ, editors. Contemporary Cardiology: Minimally Invasive Cardiac Surgery. Humana Press Inc., Totowa, NJ. Copyright 1999.

  2. Goldstein DJ, Oz MC, editors. Cardiac Assist Devices. Futura Publishing. Copyright 2000.

  3. Goldstein DJ, Oz MC, editors. Minimally Invasive Cardiac Surgery. Humana Press Inc., Totowa, NJ. Second Edition. Copyright 2003.

Editorial Activities

  • Ad Hoc Reviewer for Annals of Thoracic Surgery
  • Ad Hoc Reviewer for Journal of Thoracic and Cardiovascular surgery
  • Ad Hoc Reviewer for New England Journal of Medicine
  • Ad Hoc Reviewer for Journal of Heart and Lung Transplantation
  • Ad Hoc Reviewer for Transplantation

Selected Abstracts and Presentations

  1. Induction of anti-HIV gp160 Antibodies in Rabbit by Sensitization With Monoclonal Anti-Idiotypes Specific for Anti-Envelope Peptide. Presented at the International Conference in AIDS vaccine development: Third Annual Meeting of the National Cooperative Vaccine Development for AIDS, 1990.

  2. Use of Aprotinin in LVAD Recipients Reduces Blood Loss and Associated Right Heart Failure. Presented at the Third Meeting of the Society of Thoracic Surgeons, Circulatory Support. Pittsburgh, PA, 1994.

  3. Isolated Direct Bilirubinemia in LVAD Patients: Etiology and Prognosis. Presented at the Third Meeting of the Society of Thoracic Surgeons, Circulatory Support. Pittsburgh, PA. 1994.

  4. Controlled Veno-Arterial Shunting Can Treat Right Heart Failure in LVAD and Heart Transplant Recipients. Presented at the 67th Scientific Session of the American Heart Association, Dallas, TX, 1993. Circulation 88;4(2) Abstract.

  5. Selection Scale Predicts Successfully Patients Receiving Long Term Implantable LVAD. Presented at the 67th Scientific Session of the American Heart Association, Dallas, TX, 1993. Circulation 88;4(2) Abstract.

  6. Abiomed Ventricular Assist Device as a Bridge to Transplantation. Presented at the 44th Annual Scientific Sessions of the American College of Cardiology, New Orleans, LA. JACC 1995; Abstract 916-87, 75A.

  7. Ventricular Interdependence in Explanted Human Hearts. Presented at the 44th Annual Scientific Sessions of the American College of Cardiology, New Orleans, LA. JACC 1995; Abstract 932-91, 120A.

  8. Duration of LVAD Support Affects Transplant Survival. Presented at the 15th Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation, San Francisco, CA, 1994.

  9. Perfusion Technique for Treatment of Right Heart Failure. Presented at the Annual Meeting of the American Association of Clinical Perfusion, Palm Springs, CA, 1994.

  10. Inhaled Nitric Oxide is Not a Negative Inotrope in a Porcine Model of Pulmonary Hypertension. Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-182 Abstract

  11. Circulatory Resuscitation With 30 day Left Ventricular Device Support Reduces Interleukins 6 and 8 Levels. Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-49

  12. Long Term Implantable Left Ventricular Assist Devices for Outpatient Therapy of Patients With End Stage Heart Disease: An Alternative to Transplantation? Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-378.

  13. Outpatient LVAD Support: A New Destination Rather Than a Bridge. Presented at the Society of Thoracic Surgeons, Orlando, Florida 1995.

  14. Inhaled Nitric Oxide is Not a Myocardial Depressant in a Porcine Model of Heart Failure. Presented at the New York Society of Thoracic Surgery, 1996.

  15. Cyclosporine-Induced End Stage Nephropathy After Cardiac Transplantation: Incidence and Progression. Presented at the 16th Annual meeting of the International Society for Heart and Lung Transplantation, New York 1996. J Heart and Lung Transplant 1996;15:S99.

  16. Liver Dysfunction and Blood Product Replacement After Circulatory Arrest for Aortic Surgery. Anesthesia and Analgesia 1996;82:S108.

  17. Experience with Long Term LVAD Support: Implications for Permanent Use. J Heart Lung Transplant 1998;17 [Abstract]:21. Presented at the 18th Annual Meeting of the International Society for Heart Lung Transplantation, Chicago 1998.

  18. Left Ventricular Function in a Porcine Model of Dilated Cardiomyopathy During Left Ventricular Reduction Surgery. American College of Surgeons, 1998.

  19. Longevity of Lead Systems in Patients with Implantable Cardioverter-Defibrillators: a 13-year Experience. 20th Annual Scientific Sessions North American Society of Pacing and Electrophysiology, Toronto, Ontario, 1999.

  20. Right Ventricular Dysfunction and Organ Failure in LVADs: A Continuing Problem. Presented at the Fifth International Conference on Circulatory Support Devices for Severe Cardiac Failure, New York, 2000.

  21. Combined Off-Pump Myocardial Revascularization and Carotid Endarterectomy: Early Experience. American College of Surgeons, Chicago, 2000.

  22. Adult Cardiac Assist Devices. Sixth Annual Extracorporeal Membrane Oxygenation Meeting, New Jersey, 2001.

  23. Transesophageal Echocardiography Identifies High Embolic Risk of Atherosclerotic Plaque and Provides Guidance in Selecting Optimal Surgical Approach for Prevention of Perioperative Stroke. Scientific Sessions, American Heart Association, Anaheim, 2001.

  24. Beating Heart Revascularization in Octagenarians: Early Outcome Analysis. Presented at the 5th Annual Meeting of the International Society for Minimally Invasive Cardiac Surgery, 2002. Heart Surg Forum 2002;5:S157.

  25. Off Pump Revascularization in Patients With Severe Left Ventricular Dysfunction: Can and Should it be Done? Presented at the 5th Annual Meeting of the International Society for Minimally Invasive Cardiac Surgery, 2002. Heart Surg Forum 2002;5:S158

  26. Worldwide Experience with the MicroMed-DeBakey Ventricular Assist Device. Presented at the Scientific Sessions of the American Heart Association, Chicago, 2002.

  27. American Experience with the MicroMed DeBakey VAD as a Bridge to Transplantation: Initial Safety and Feasibility Trial. International Society of Heart and Lung Transplantation, Vienna, 2003.

  28. Sirolimus-tacrolimus based immunosuppression vs. traditional immunosuppression in de novo heart transplant recipients – a single center analysis. American Transplant Congress, 2003

Submitted Abstracts

  • Impact of mechanical support and device type on outcomes following transplantation. Society for Thoracic Surgeons, 2008

  • Role of Race in Heart Transplantation. Society for Thoracic Surgeons, 2008

 

Invited Faculty, CME Talks, Panels

  2001    Heart Transplantation and Mechanical Support. Grand Rounds, Monmouth Medical Center, N.J.
       
  2001    Left Ventricular Assist Devices. Grand Rounds, Saint Barnabas Hospital, Livingston, N.J.
       
  2001    Options for Mechanical Support in Adults. Sixth Annual ECMO Conference. Livingston, N.J.
       
  2001    Surgical Management of Heart Failure. Quarterly Medical Staff Meeting, Newark Beth Israel, Newark, N.J.
       
  2002     Surgical Management of End-Stage Heart Disease. Grand Rounds, Morristown Memorial Hospital, Morristown, N.J.
       
  2002     REMATCH Trial: A Paradigm Shift ?. Grand Rounds, Strong Memorial Hospital, Rochester, N.Y.
       
  2002     Mechanical Support for the Management of Advanced Heart Failure. Heart Council of Long Island Heart Failure Meeting, Melville, N.Y.
       
  2002     The MicroMed-DeBakey Axial Flow Pump. 42th Annual ASAIO meeting, New York,   N.Y.
 
 
  1997   Overview of Mechanical Pumps. Moderator. Cleveland Clinic Foundation, STS Circulatory Support Meeting, Cleveland, Ohio.
 
 
  2002     Bleeding and LVADs: Adding Insult to Injury. Cleveland Clinic Foundation, STS Circulatory Support Meeting, Cleveland, Ohio.
     
  2003        Mechanical Support and the REMATCH Trial: The Dawn of a New Era?. Grand Rounds, St-Luke’s-Roosevelt Medical Center, N.Y.
     
  2003        End-Stage Heart Failure – Heart Transplantation and Beyond. Grand Rounds, Newark Beth Israel, N.Y.
     
  2003        American Experience With the MicroMed VAD as a Bridge to Transplantation. Investigator’s Meeting. Washington, D.C.
     
  2003        Selection Criteria for MicroMed VAD Support. Investigator’s Meeting. Washington, D.C.
     
  2003        Surgical Options in Heart Failure Management. Cardiac Nursing Symposium, Newark, N.J.
  2003        End-Stage Heart Failure – Heart Transplantation and Beyond .Cardiology Grand Rounds, New York University, N.Y.
       
  2003        Annual Cardiac Symposium, Staten Island University, New York
       
  2004     Surgical Treatment of Heart Failure: State of the Art. 6th Annual New Jersey Perfusion Symposium. Livingston, N.J.
       
  2004     My Worse Case Scenario. STS Current Strategies for Heart Failure Management Meeting. Louisville, Ky.
       
  2005    Surgical Considerations in Device Therapy. Moderator. Mechanical and Biological Cardiac Support Meeting: Recovery, Replacement and Repair. Dallas, Texas.
       
  2005    LVAD 101. Cardiothoracic Surgery Grand Rounds. Montefiore Medical Center, N.Y.
       
  2006     2006  State of the Art in Mechanical Support. Cardiology Grand Rounds, Einstein Hospital, N.Y.
       
  2006     2006  Surgical Options for the Patient with Advanced Heart Failure. General Surgery Grand Rounds. Montefiore Medical Center, N.Y.
 
 
  2005    2005  The Bumpy Road to Destination Therapy. First Annual Heart Failure Symposium. Montefiore Medical Center, N.Y.
 
 
  2006     2006  What Can the Surgeon Do For You?. Cardiothoracic Surgery Grand Rounds, North Shore Hospital, Manhasset, N.Y.
     
  2006     2006    Surgical Options for the Patient with Advanced Heart Failure. General Surgery Grand Rounds. Our Lady of Mercy Hospital, Bronx, N.Y.
     
  2006     Surgical Management of End-Stage Heart Disease. Cardiology Grand Rounds. Maimonides Hospital, Brooklyn, N.Y.




 

© 2010 Montefiore Medical Center